美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kyntra Bio Inc

6.75

-0.3100-4.39%

盤後：6.750.00000.00%16:10 EDT

成交量：5.03萬

成交額：34.28萬

市值：2,730.68萬

市盈率：0.15

高：7.05

開：6.96

低：6.64

收：7.06

52周最高：12.60

52周最低：4.85

股本：404.54萬

流通股本：362.37萬

量比：0.95

換手率：1.39%

股息：- -

股息率：- -

每股收益(TTM):45.37

每股收益(LYR):45.37

淨資產收益率：--

總資產收益率：-16.96%

市淨率：-0.91

市盈率(LYR):0.15

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Kyntra Bio Inc

交易所：

NASDAQ

成立時間：

1993

員工人數：

34

公司地址：

350 Bay Street,Suite 100 #6009,San Francisco,California,United States

官網：

http://www.kyntrabio.com

郵編：

94133

電話：

傳真：

415 978 1902

簡介：

Kyntra Bio, Inc.於1993年在美國特拉華州註冊成立。該公司是一家生物製藥公司，專註於癌症生物學和貧血前沿領域的新療法開發。該公司正在開發FG-3246，這是一種潛在的靶向CD46的first-in-class抗體藥物偶聯物，用於治療轉移性去勢抵抗性前列腺癌和潛在的其他癌症。該計劃還包括FG-3180的開發，這是一種相關的CD46靶向正電子發射斷層掃描生物標誌物和顯像劑。

董事

名稱

職位

Thomas B. Neff

Chairman, Founder, Chief Executive Officer, and Director

James A. Schoeneck

董事

Jeffrey L. Edwards

董事

Jeffrey W. Henderson

董事

Jorma Routti

董事

Julian N. Stern

董事

Kalevi Kurkijarvi

董事

Roberto Pedro Rosenkranz

董事

Rory B. Riggs

董事

Thomas F. Kearns

董事

Toshinari Tamura

董事

股東

名稱

職位

Thomas B. Neff

Chairman, Founder, Chief Executive Officer, and Director

Pat Cotroneo

Vice President, Finance, and Chief Financial Officer

K. Peony Yu

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KYNB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KYNB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","market":"US","secType":"STK","nameCN":"Kyntra Bio Inc","latestPrice":6.75,"timestamp":1774382400000,"preClose":7.06,"halted":0,"volume":50278,"hourTrading":{"tag":"盘后","latestPrice":6.75,"preClose":6.75,"latestTime":"16:10 EDT","volume":1,"amount":6.75,"timestamp":1774383004564,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.043909348441926295,"floatShares":3623701,"shares":4045445,"eps":45.371456,"marketStatus":"未開盤","change":-0.31,"latestTime":"03-24 16:00:00 EDT","open":6.96,"high":7.05,"low":6.6401,"amount":342760.4517,"amplitude":0.058059,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":45.371456,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":0,"adr":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":7.06,"postHourTrading":{"tag":"盘后","latestPrice":6.75,"preClose":6.75,"latestTime":"16:10 EDT","volume":1,"amount":6.75,"timestamp":1774383004564,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.954538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","floatShares":3623701,"roa":"-16.96%","roe":"--","lyrEps":45.371456,"volumeRatio":0.954538,"shares":4045445,"dividePrice":0,"high":7.05,"amplitude":0.058059,"preClose":7.06,"low":6.6401,"week52Low":4.85,"pbRate":"-0.91","psRate":"4.24","week52High":12.6,"institutionHeld":0,"latestPrice":6.75,"eps":45.371456,"divideRate":0,"volume":50278,"delay":0,"ttmEps":45.371456,"open":6.96,"prevYearClose":8.78,"prevWeekClose":7.13,"prevMonthClose":6.93,"prevQuarterClose":8.78,"fiveDayClose":7.37,"twentyDayClose":7.28,"sixtyDayClose":8.585},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYNB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-16","symbol":"KYNB","fiscalQuarterEnding":"2025/12","expectedEps":-3.89,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"post","actualEps":-3.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYNB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYNB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1734494400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYNB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYNB","date":"2026-03-23","current":0.148772,"percent":0.64,"low":0.128311,"twenty":0.133564,"median":0.147821,"eighty":0.163953,"high":0.18215,"avg":0.1502,"sd":0.015395,"marketCap":28853876},"quantilePoints":[{"date":"2026-01-09","current":0.17821,"twenty":0.178998,"median":0.18018,"eighty":0.181362,"marketCap":38431727},{"date":"2026-01-16","current":0.170144,"twenty":0.170369,"median":0.172958,"eighty":0.17821,"marketCap":36692186},{"date":"2026-01-23","current":0.168268,"twenty":0.168268,"median":0.171269,"eighty":0.17821,"marketCap":36287641},{"date":"2026-01-30","current":0.150259,"twenty":0.160389,"median":0.169206,"eighty":0.172958,"marketCap":32404014},{"date":"2026-02-06","current":0.140692,"twenty":0.153073,"median":0.163953,"eighty":0.171457,"marketCap":30340837},{"date":"2026-02-13","current":0.140317,"twenty":0.147445,"median":0.160201,"eighty":0.171269,"marketCap":30259928},{"date":"2026-02-20","current":0.14707,"twenty":0.146282,"median":0.158795,"eighty":0.170369,"marketCap":31716288},{"date":"2026-02-27","current":0.13075,"twenty":0.144894,"median":0.154199,"eighty":0.170144,"marketCap":28196751},{"date":"2026-03-06","current":0.129155,"twenty":0.137315,"median":0.150635,"eighty":0.168643,"marketCap":27852888},{"date":"2026-03-13","current":0.131688,"twenty":0.133714,"median":0.147445,"eighty":0.165191,"marketCap":28399023},{"date":"2026-03-20","current":0.161033,"twenty":0.133301,"median":0.147633,"eighty":0.164047,"marketCap":29541837},{"date":"2026-03-23","current":0.157283,"twenty":0.133564,"median":0.147821,"eighty":0.163953,"marketCap":28853876}],"updateTime":1774419869004},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":28484,"yearFounded":1993,"employeeNum":34,"address":"350 Bay Street,Suite 100 #6009,San Francisco,California,United States","zipCode":"94133","officePhone":"415 978 1200","officeFax":"415 978 1902"},"stockCompanyDetail":{"websiteUrl":"http://www.kyntrabio.com","stockEarnings":[{"period":"1week","weight":-0.0841},{"period":"1month","weight":-0.1887},{"period":"3month","weight":-0.2137},{"period":"6month","weight":-0.4488},{"period":"1year","weight":-0.2683},{"period":"ytd","weight":-0.2312}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Kyntra Bio, Inc.於1993年在美國特拉華州註冊成立。該公司是一家生物製藥公司，專註於癌症生物學和貧血前沿領域的新療法開發。該公司正在開發FG-3246，這是一種潛在的靶向CD46的first-in-class抗體藥物偶聯物，用於治療轉移性去勢抵抗性前列腺癌和潛在的其他癌症。該計劃還包括FG-3180的開發，這是一種相關的CD46靶向正電子發射斷層掃描生物標誌物和顯像劑。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.171748},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.039992},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.057789},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.133734},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.039352},{"month":6,"riseRate":0.636364,"avgChangeRate":-0.001658},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.034699},{"month":8,"riseRate":0.363636,"avgChangeRate":0.01162},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.009378},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.070226},{"month":11,"riseRate":0.727273,"avgChangeRate":0.07854},{"month":12,"riseRate":0.636364,"avgChangeRate":0.096082}],"exchange":"NASDAQ","name":"Kyntra Bio Inc","nameEN":"Kyntra Bio Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KYNB\",market:\"US\",,,undefined,":{"directors":[{"name":"Thomas B. Neff","position":"Chairman, Founder, Chief Executive Officer, and Director"},{"name":"James A. Schoeneck","position":"董事"},{"name":"Jeffrey L. Edwards","position":"董事"},{"name":"Jeffrey W. Henderson","position":"董事"},{"name":"Jorma Routti","position":"董事"},{"name":"Julian N. Stern","position":"董事"},{"name":"Kalevi Kurkijarvi","position":"董事"},{"name":"Roberto Pedro Rosenkranz","position":"董事"},{"name":"Rory B. Riggs","position":"董事"},{"name":"Thomas F. Kearns","position":"董事"},{"name":"Toshinari Tamura","position":"董事"}],"executives":[{"name":"Thomas B. Neff","position":"Chairman, Founder, Chief Executive Officer, and Director"},{"name":"Pat Cotroneo","position":"Vice President, Finance, and Chief Financial Officer"},{"name":"K. Peony Yu","position":"Chief Medical Officer"}]}}}